On the one hand, it is highly likely that elevated levels of GDF15 actively participate in driving nausea, emesis, and cachexia syndromes in the context of cytotoxic chemotherapy, cancer, and other severe systemic diseases. The gene discussed is GDF15; the disease is cancer.